February 24, 2020 11:46 AM EST

Eli Lilly scores expanded MACE label for Trulicity; Gilead's CAR-T Yescarta gets in China review line

Amber Tong

→ The FDA has expanded the label for Eli Lilly‘s type 2 diabetes drug Trulicity, saying that it is now

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

H1 buys General Catalyst-backed Ribbon Health

Anne Wojcicki and Regeneron set to duke it out in restarted 23andMe auction

FDA's Prasad explains rationale behind pausing Valneva's chikungunya vaccine in seniors

Struggling biotechs succumb to icy market, as money dries up and clinical bets don’t pay off

Exclusive: Tech VC Amplify raises $200M for first biotech fund, hires Elliot Hershberg as new partner

sponsored

Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy ...